SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Transfusion-transmitted infectious diseases
0 references·16 citing·45 second hop
Transfusion-transmitted infectious diseases (2009)Transfusion-transmitted infectious diseas…Time Trend and Prevalence Analysis of Transfusion Transmitted Infections among Blood Donors: A Retrospective Study from 2001 to 2016 (2023)Time Trend and Prevalence Ana…Prevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three‐year retrospective study (2018)Prevalence of hepatitis B vir…Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Emerging Infectious Diseases …Head‐to‐head comparison between two screening systems for HB s AG , anti‐ HB c, anti‐ HCV and HIV combination immunoassays in an international, multicentre evaluation study (2015)Head‐to‐head comparison betwe…Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems (2014)Screening tests for hepatitis…Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis in blood donors in a tertiary health facility in south eastern Nigeria (2014)Prevalence of human immunodef…Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors (2014)Prevalence and trends of mark…HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia (2013)HBsAg, anti-HCV, anti-HIV 1/2…Donor cycle and donor segmentation: new tools for improving blood donor management (2013)Donor cycle and donor segment…Blood supply under threat (2013)Blood supply under threatThe yield of temporary exclusion of blood donors, exposed to emerging infections abroad (2012)The yield of temporary exclus…The Politics of Blood (2012)The Politics of BloodSeroprevalencia de marcadores de infecciones transmisibles por vía transfusional en banco de sangre de Colombia (2012)Seroprevalencia de marcadores…Risques viraux émergents en transfusion sanguine (2011)Risques viraux émergents en t…Le risque infectieux viral chez le polytransfusé : séroprévalence de sept agents viraux dans le centre tunisien (2011)Le risque infectieux viral ch…Assessing Emerging Infectious Threats to Blood Safety for the Blood Disorders Community (2010)Assessing Emerging Infectious…Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania (2006)Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years (2010)Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study (2015)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Awareness of and attitude towards blood donation in students at the Semnan University of Medical Sciences (2018)The effect of short‐term, temporary deferral on future blood donation (1998)The blood‐donation experience: perceived physical, psychological and social impact of blood donation on the donor (2003)Exploring the pattern of blood donor beliefs in first‐time, novice, and experienced donors: differentiating reluctant altruism, pure altruism, impure altruism, and warm glow (2011)Reasons to end the donor career: a quantitative study among stopped blood donors in the Netherlands (2017)Effective methods for reactivating inactive blood donors: a stratified randomised controlled study (2020)Web-Based Short Video Intervention and Short Message Comparison of Repeat Blood Donation Behavior Based on an Extended Theory of Planned Behavior: Prospective Randomized Controlled Trial Study (2022)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)* (2012)Assessment of rapid diagnostic tests and fourth‐generation Enzyme‐Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first‐time blood donors in Libreville (Gabon) (2018)Comparative Evaluation and Measure of Accuracy of ELISAs, CLIAs, and ECLIAs for the Detection of HIV Infection among Blood Donors in China (2020)Retrospective Study of the Seroprevalence of HIV, HCV, and HBV in Blood Donors at a Blood Bank of Western Mexico (2021)Safety of the Blood Supply in Latin America (2005)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013 (2015)Séroprévalence des marqueurs viraux sur les dons du sang au Centre de Transfusion Sanguine, Hôpital Militaire d’Instruction Mohammed V de Rabat (2016)Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016 (2018)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique (2011)Residual risk of transfusion in Ghana (2001)Évaluation du risque infectieux résiduel chez les donneurs de sang au Centre national de transfusion sanguine de Conakry (2004)Transfusion medicine and safety (2009)Contrôle de qualité virologique du sang transfusé dans la ville de Bukavu, Sud Kivu, République Démocratique du Congo (2018)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency (2020)Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review (2022)Challenges for the maintaining the microbiological safety of the UK blood supply (2023)The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)Blood Transfusion Safety in Africa: A Literature Review of Infectious Disease and Organizational Challenges (2011)Seroprevalence and trends of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Syrian blood donors at Damascus University Blood Center between 2004 and 2021 (2023)Seroprevalence, trends, and risk factors of hepatitis B and C among family replacement blood donors; a 7-year retrospective study at Sunyani Municipal Hospital, Ghana (2023)The Structure of Scientific Revolutions (1963)The consequences of modernity (1990)Risk Society, Towards a New Modernity (1994)Revaluing donor and recipient bodies in the globalised blood economy: Transitions in public policy on blood safety in the United Kingdom (2013)Risky Bodies in the Plasma Bioeconomy (2014)Donor blood screening and moral responsibility: how safe should blood be? (2016)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2014Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors46 cited
  • 2013Blood supply under threat35 cited
  • 2017Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk33 cited
  • 2012The Politics of Blood30 cited
  • 2013Donor cycle and donor segmentation: new tools for improving blood donor management28 cited
  • 2012Seroprevalencia de marcadores de infecciones transmisibles por vía transfusional en banco de sangre de Colombia25 cited
  • 2013HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia25 cited
  • 2014Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems25 cited
  • 2018Prevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three‐year retrospective study22 cited
  • 2011Le risque infectieux viral chez le polytransfusé : séroprévalence de sept agents viraux dans le centre tunisien22 cited
  • 2011Risques viraux émergents en transfusion sanguine20 cited
  • 2023Time Trend and Prevalence Analysis of Transfusion Transmitted Infections among Blood Donors: A Retrospective Study from 2001 to 201619 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2014
Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis in blood donors in a tertiary health facility in south eastern Nigeria
19 cited
  • 2012The yield of temporary exclusion of blood donors, exposed to emerging infections abroad15 cited
  • 2010Assessing Emerging Infectious Threats to Blood Safety for the Blood Disorders Community14 cited
  • 2015Head‐to‐head comparison between two screening systems for HB s AG , anti‐ HB c, anti‐ HCV and HIV combination immunoassays in an international, multicentre evaluation study11 cited